Dexamethasone induces rapid promotion of norepinephrine-mediated vascular smooth muscle cell contraction

Molecular Medicine Reports

Volumn 7, Issue 2, 2013, Pages 549-554

  Zhang, Ting ^a   Shi, Wen Lei ^a,b   Tasker, Jeffrey G ^c   Zhou, Jiang Rui ^a   Peng, Yun Li ^a   Miao, Chao Yu ^d   Yang, Yong Ji ^a   Jiang, Chun Lei ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b BETHUNE INTERNATIONAL PEACE HOSPITAL   (China)

^c Tulane University   (United States)

^d Department of Pharmacology ^*  (China)

Author keywords

Contraction; Dexamethasone; Norepinephrine; Rapid promotion; Vascular smooth muscle cell

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; DEXAMETHASONE; HEAT SHOCK PROTEIN 27; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MYOSIN LIGHT CHAIN; NORADRENALIN; RHO KINASE; SYNAPTOPHYSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; IN VITRO STUDY; MUSCLE FIBER CONTRACTION; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; SEPTIC SHOCK; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; DEXAMETHASONE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; MYOSIN LIGHT CHAINS; NOREPINEPHRINE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN PHOSPHATASE 1; RATS; RHO-ASSOCIATED KINASES; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; VASOCONSTRICTOR AGENTS;

EID: 84873803996     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.1196     Document Type: Article

References (35)

1. Somlyo AP and Somlyo AV: Signal transduction and regulation in smooth muscle. Nature 372: 231-236, 1994.
2. Kamm KE and Stull JT: The function of myosin and myosin light chain kinase phosphorylation in smooth muscle. Annu Rev Pharmacol Toxicol 25: 593-620, 1985.
3. Wickman G, Lan C and Vollrath B: Functional roles of the rho/rho kinase pathway and protein kinase C in the relevance regulation of cerebrovascular constriction mediated by hemoglobin: relevance to subarachnoid hemorrhage and vasospasm. Circ Res 92: 809-816, 2003.
4. Ito M, Nakano T, Erdodi F and Hartshorne DJ: Myosin phosphatase: structure, regulation and function. Mol Cell Biochem 259: 197-209, 2004.
5. Somlyo AP and Somlyo AV: Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non muscle myosin II. J Physiol 522: 177-185, 2000.
6. Hedges JC, Oxhorn BC, Carty M, Adam LP, Yamboliev IA and Gerthoffer WT: Phosphorylation of caldesmon by ERK MAP kinases in smooth muscle. Am J Physiol Cell Physiol 278: 718-726, 2000.
7. Yamboliev IA, Hedges JC, Mutnick JL, Adam LP and Gerthoffer WT: Evidence for modulation of smooth muscle force by the p38 MAP kinase/HSP27 pathway. Am J Physiol Heart Circ Physiol 278: 1899-1907, 2000.
8. Gorenne I, Su X and Moreland RS: Caldesmon phosphorylation is catalyzed by two kinases in permeabilized and intact vascular smooth muscle. J Cell Physiol 198: 461-469, 2004.
9. Zhou J, Li M, Liu L, Sheng CQ, Li Z, Wang Y, Zhou JR, Jiang ZP, Chen YZ and Jiang CL: A novel strategy for development of glucocorticoids through non-genomic mechanism. Cell Mol Life Sci 9: 1-10, 2010.
10. Zhou J, Liu DF, Liu C, Kang ZM, Shen XH, Chen YZ, Xu T and Jiang C: Glucocorticoids inhibit degranulation of mast cells in allergic asthma via nongenomic mechanism. Allergy 63: 1177-1185, 2008.
11. Sun HW, Miao CY, Liu L, Zhou J, Su DF, Wang YX and Jiang CL: Rapid inhibitory effect of glucocorticoids on airway smooth muscle contractions in guinea pigs. Steriods 71: 154-159, 2006.
12. Liu L, Wang YX, Zhou J, Long F, Sun HW, Liu Y, Chen YZ and Jiang CL: Rapid nongenomic inhibitory effects of glucocorticoids on human neutrophil degranulation. Inflam Res 54: 37-41, 2005.
13. Yang S and Zhang L: Glucocorticoids and vascular reactivity. Curr Vasc Pharmacol 2: 1-12, 2004.
14. Mansart A, Bollaert PE, Giummelly P, Capdeville-Atkinson C and Atkinson J: Effects of dexamethasone and L-canavanine on the intracellular calcium-contraction relation of the rat tail artery during septic shock. Am J Physiol Heart Circ Physiol 291: H1177-H1182, 2006.
15. Takakura K, Xiaohong W, Takeuchi K, Yasuda Y and Fukuda S: Deactivation of norepinephrine by peroxynitrite as a new pathogenesis in the hypotension of septic shock. Anesthesiology 98: 928-934, 2003.
16. Jeon SB, Jin F, Kim JI, Kim SH, Suk K, Chae SC, Jun JE, Park WH and Kim IK: A role for rho kinase in vascular contraction evoked by sodium fluoride. Biochem Biophys Res Commun 343: 27-33, 2006.
17. 2+ sensitivity of smooth muscle and nonmuscle myosin: modulated by G proteins, kinases andmyosin phosphatase. Physiol Rev 83: 1325-1358, 2003.
18. Mansart A, Bollaert PE, Seguin C, Levy B, Longrois D and Mallie JP: Hemodynamic effects of early versus late glucocorticoid administration in experimental septic shock. Shock 19: 38-44, 2003.
19. Zaloga GP and Marik P: Hypothalamic-pituitary-adrenal insufficiency. Crit Care Clin 17: 25-41, 2001.
20. Annane D, Bellissant E, Sebille V, Lesieur O, Mathieu B, Raphael JC and Gajdos P: Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve. Br J Clin Pharmacol 46: 589-597, 1998.
21. Hilgers RH and Webb RC: Molecular aspects of arterial smooth muscle contraction: focus on Rho. Exp Biol Med 230: 829-835, 2005.
22. 2+ sensitization in rat ileal longitudinal smooth muscle. Am J Physiol Gastrointest Liver Physiol 293: 699-710, 2007.
23. Loirand G, Guerin P and Pacaud P: Rho kinases in cardiovascular physiology and pathophysiology. Circ Res 98: 322-334, 2006.
24. Noma K, Oyama N and Liao JK: Physiological role of ROCKs in the cardiovascular system. Am J Physiol Cell Physiol 290: C661-C668, 2006.
25. Shimokawa H and Takeshita A: Rho-kinase is an important therapeutic target in cardiovascular medicine. Arterioscler Thromb Vasc Biol 25: 1767-1775, 2005.
26. Hirokazu T, Hiroki C, Tadashi I, Jun K, Haruhiko M, Yoshisato T, Miyako T, Kazuhiko Y, Masaki N and Hisashi S: Diverse activation states of RhoA in human lung cancer cells: contribution of G protein coupled receptors. Int J Oncol 30: 709-715, 2007.
27. Bellizzi A, Mangia A, Chiriatti A, Petroni S, Quaranta M, Schittulli F, Malfettone A, Cardone RA, Paradiso A and Reshkin SJ: RhoA protein expression in primary breast cancers and matched lymphocytes is associated with progression of the disease. Int J Mol Med 22: 25-31, 2008.
28. 2+ independent contractions induced by phorbol-12, 13-dibutyrate. Clin Exp Pharmacol Physiol 36: 256-261, 2009.
29. Li T, Liu L, Liu J, Ming J, Xu J, Yang G and Zhang Y: Mechnisms of Rho kinase regulation of vascular reactivity following hemorrhagic shock in rats. Shock 29: 65-70, 2008.
30. Chiba Y, Goto K, Hirahara M, Sakai H and Misawa M: Glucocorticoids ameliorate antigen-induced bronchial smooth muscle hyperresponsiveness by inhibiting upregulation of RhoA in rats. J Pharmacol Sci 106: 615-625, 2008.
31. Berridge MJ: Smooth muscle cell calcium activation mechanisms. J Physiol 586: 5047-5061, 2008.
32. 2+], myosin phosphorylation and force in smooth muscle. Am J Physiol 41: 1960-1967, 1997.
33. Tang DC, Xiang JZ and Lu WT: Calponin: a new regulatory protein for smooth muscle contraction. Prog Biochem Biophys 23: 325-329, 1996.
34. Matrougui K, Tanko LB, Loufrani L, Gorny D, Levy BI, Tedgui A and Henrion D: Involvement of rho kinase and the actin filament network in angiotensin β induced contraction and extracellular signal-regulated kinase activity in intact rat mesenteric resistance arteries. Arterioscler Thromb Vasc Biol 21: 1288-1293, 2001.
35. Roberts RE: The role of Rho kinase and extracellular regulated kinase-mitogen-activated protein kinase in α2-adrenoceptor-mediaed vasoconstriction in the porcine palmar lateral vein. J Pharmacol Exp Ther 311: 742-747, 2004.